- Tytuł:
- Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study
- Autorzy:
- Źródło:
- In The Lancet Infectious Diseases November 2020 20(11):1290-1301
Czasopismo naukowe